NewAmsterdam Pharma Company NAMS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's total assets?
- NewAmsterdam Pharma Company (NAMS) reported total assets of $732.64M in Q1 2026.
- How has NewAmsterdam Pharma Company's total assets changed year-over-year?
- NewAmsterdam Pharma Company's total assets decreased by 10.5% year-over-year, from $818.41M to $732.64M.
- What is the long-term trend for NewAmsterdam Pharma Company's total assets?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's total assets has grown at a 17.1% compound annual growth rate (CAGR), from $478.5M to $769.28M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.